Corgenix to develop diagnostic tests for bioterrorism agents under multi-million dollar NIH contract
Company expands presence into BioDefense
14-Nov-2005 -
Corgenix Medical Corporation, in partnership with Tulane University, the U.S. Army Medical Research
Institute of Infectious Diseases (USAMRIID) and two corporate partners, will develop and manufacture improved diagnostic tests for viral hemorrhagic fevers under a $3.8 million grant awarded by the ...
arenaviruses
diagnostic tests
hemorrhagic fevers
+3